Announcement of Resolutions of the 11th (Provisional) Meeting of the 11th Board of Directors of Lukang Pharmaceutical
Securities code: 600789 Securities abbreviation: Lukang Pharmaceutical Announcement number: 2025-054
Shandong Lukang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Eleventh (Provisional) Meeting of the Eleventh Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
The 11th (temporary) meeting of the 11th Board of Directors of Shandong Lukang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held at 9:30 am on December 11, 2025 in the A1310 conference room of the company's high-tech park through on-site and communication methods. The notice of this meeting was sent by email on December 8, 2025. The meeting was supposed to be attended by 9 directors, but 9 people actually participated in the voting. The company's senior managers attended the meeting. The meeting complied with the provisions of the Company Law and the Company's Articles of Association, and the resolutions formed were legal and valid. The meeting was chaired by Chairman Mr. Peng Xin. After careful discussion, the following proposals were reviewed and approved:
1. "Proposal on Increasing Capital of Two Wholly-Owned Subsidiaries"
For details, please refer to the "Announcement on Increasing Capital to Two Wholly-Owned Subsidiaries" (Announcement No.: 2025-055) published by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) on the same day.
9 votes in favor, 0 votes against, 0 abstentions
- "Proposal on Opening a Special Account for Raised Funds and Authorizing the Signing of a Supervision Agreement for the Special Account for Raised Funds"
It was agreed that the company would open four special accounts for raised funds at the Jining Branch of Industrial and Commercial Bank of China Co., Ltd., Jining Xicheng Branch of China Construction Bank Co., Ltd., Jining Jinyu Road Branch of Postal Savings Bank of China Co., Ltd. and Jining Branch of China Merchants Bank Co., Ltd., and the company's wholly-owned subsidiary Shandong Lukang Biological Pesticide Co., Ltd. would open a special account for raised funds at Jining Branch of China Merchants Bank Co., Ltd. and sign a special account supervision agreement for raised funds after the special account for raised funds was opened. The board of directors authorizes the company's management and relevant personnel to handle specific matters such as the opening of a special account for raised funds and the signing of a supervision agreement for the special account for raised funds.
9 votes in favor, 0 votes against, 0 abstentions
- "Related Transaction Proposal Regarding the Signing of the "Trademark License Agreement" with Related Parties" In view that the "Trademark License Agreement" signed between the company and Hualu Group is about to expire, the company and Hualu Group plan to renew the "Trademark License Agreement".
Directors Zhang Chengyong and Liu Chengtong abstained from voting on this proposal.
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved at a special meeting of the company's independent directors.
For details, please refer to the "Announcement on Related Transactions Regarding the Signing of the "Trademark License Agreement" with Related Parties" published by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) on the same day (announcement number: 2025-056).
Announcement is hereby made.
Board of Directors of Shandong Lukang Pharmaceutical Co., Ltd.
December 12, 2025